Biomerica Inc (BMRA) USD0.08

Sell:$3.04Buy:$3.18$0.11 (3.48%)

Prices delayed by at least 15 minutes
Sell:$3.04
Buy:$3.18
Change:$0.11 (3.48%)
Prices delayed by at least 15 minutes
Sell:$3.04
Buy:$3.18
Change:$0.11 (3.48%)
Prices delayed by at least 15 minutes

Company Information

About this company

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Key people

Zackary S. Irani
Chief Executive Officer, Director
Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Gary Lu
Chief Financial Officer
Scott Madel
Chief Commercial Officer
Eric Chin
Independent Director
Jane F. Emerson
Independent Director
David Moatazedi
Independent Director
Click to see more

Key facts

  • EPIC
    BMRA
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US09061H4065
  • Market cap
    $8.02m
  • Employees
    63
  • Shares in issue
    2.55m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.